Analysis of dose distribution in proton therapy for lung cancer with MCNP code

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Proton beam characteristics for proton therapy have been obtained by simulation method using MCNP6 software. The proton beam is modelled as a monodirectional disk with a diameter of 3 cm is 23 cm from the left lung cancer, a sphere with a diameter of 3 cm. The variation of proton beam energy that produces the best isodose in cancer cells is 94 MeV, 104 MeV, and 112 MeV fired alternately at the target from the left. The result is a total equivalent dose in cancer cells of (0.858 ± 0.003) Sv. The scattered amount received by healthy cells in the left lung was (1.39 ± 0.01) mSv, rib (0.12 ± 0.01) mSv, and skin (0.11 ± 0.01) mSv. According to the organ at risk (OAR) provisions, the scattered dose is declared safe. The simulation results prove that proton therapy is a cell targeting therapy. The dose used to kill lung cancer cells is 60 Gy, so with a proton beam of 1 μA, the total exposure time for therapy is (2.31 ± 0.01) minutes.

Cite

CITATION STYLE

APA

Rahmawati, F., Khairunnisa, A. F., Riyatun, & Suharyana. (2022). Analysis of dose distribution in proton therapy for lung cancer with MCNP code. In Journal of Physics: Conference Series (Vol. 2190). IOP Publishing Ltd. https://doi.org/10.1088/1742-6596/2190/1/012021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free